XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 182,349 $ 177,150
Trade accounts receivable, net of allowances of $479 and $391 at June 30, 2022 and December 31, 2021, respectively 96,450 79,143
Income taxes receivable 450 608
Deferred contract costs 15,460 12,904
Prepaid expenses 17,513 17,581
Other current assets 4,953 4,212
Total current assets 317,175 291,598
Equipment and leasehold improvements, net 17,334 18,045
Goodwill 823,671 845,734
Other intangible assets, net 233,557 264,593
Deferred contract costs, non-current 34,823 29,842
Other assets 39,530 30,608
Total assets 1,466,090 1,480,420
Current liabilities:    
Accounts payable 9,506 9,306
Accrued liabilities 50,761 54,022
Income taxes payable 203 167
Deferred revenues 249,374 223,031
Total current liabilities 309,844 286,526
Deferred revenues, non-current 67,578 59,097
Deferred tax liability, net 7,596 8,700
Convertible senior notes, net 363,265 362,031
Other liabilities 23,861 25,640
Total liabilities 772,144 741,994
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock, $0.001 par value, 50,000,000 shares authorized at June 30, 2022 and December 31, 2021; no shares issued and outstanding at June 30, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value, 500,000,000 shares authorized at June 30, 2022 and December 31, 2021; 120,310,047 and 119,426,064 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively 120 119
Additional paid‑in capital 987,576 913,581
Accumulated other comprehensive loss (37,574) (7,866)
Accumulated deficit (256,176) (167,408)
Total stockholders’ equity 693,946 738,426
Total liabilities and stockholders’ equity $ 1,466,090 $ 1,480,420